{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:35:38Z","timestamp":1789086938047,"version":"build-2803163510"},"reference-count":45,"publisher":"Japanese Circulation Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2016]]},"DOI":"10.1253\/circj.cj-16-0058","type":"journal-article","created":{"date-parts":[[2016,4,12]],"date-time":"2016-04-12T22:05:10Z","timestamp":1460498710000},"page":"1196-1201","source":"Crossref","is-referenced-by-count":15,"title":["Deregulation of Soluble Adhesion Molecules in Resistant Hypertension and Its Role in Cardiovascular Remodeling"],"prefix":"10.1253","volume":"80","author":[{"given":"Ana Paula","family":"de Faria","sequence":"first","affiliation":[{"name":"Laboratory of Cardiovascular Pharmacology, Faculty of Medical Sciences, University of Campinas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra Mileni Versuti","family":"Ritter","sequence":"additional","affiliation":[{"name":"Laboratory of Cardiovascular Pharmacology, Faculty of Medical Sciences, University of Campinas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9a Rodrigues","family":"Sabbatini","sequence":"additional","affiliation":[{"name":"Laboratory of Cardiovascular Pharmacology, Faculty of Medical Sciences, University of Campinas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nath\u00e1lia Batista","family":"Corr\u00eaa","sequence":"additional","affiliation":[{"name":"Laboratory of Cardiovascular Pharmacology, Faculty of Medical Sciences, University of Campinas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veridiana","family":"Brunelli","sequence":"additional","affiliation":[{"name":"Laboratory of Cardiovascular Pharmacology, Faculty of Medical Sciences, University of Campinas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Modolo","sequence":"additional","affiliation":[{"name":"Laboratory of Cardiovascular Pharmacology, Faculty of Medical Sciences, University of Campinas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heitor","family":"Moreno","sequence":"additional","affiliation":[{"name":"Laboratory of Cardiovascular Pharmacology, Faculty of Medical Sciences, University of Campinas"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, et al. Resistant hypertension: Diagnosis, evaluation, and treatment: A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. <i>Hypertension<\/i> 2008; 51: 1403\u20131419.","DOI":"10.1161\/HYPERTENSIONAHA.108.189141"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Lotufo PA, Pereira AC, Vasconcellos PS, Santos IS, Mill JG, Bensenor IM. Resistant hypertension: Risk factors, subclinical atherosclerosis, and comorbidities among adults \u2013 the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). <i>J Clin Hypertens(Greenwich)<\/i> 2015; 17: 74\u201380.","DOI":"10.1111\/jch.12433"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Bhatt DL, Kandzari DE, O\u2019Neill WW, D\u2019Agostino R, Flack JM, Katzen BT, et al. A controlled trial of renal denervation for resistant hypertension. <i>N Engl J Med<\/i> 2014; 370: 1393\u20131401.","DOI":"10.1056\/NEJMoa1402670"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Kario K, Ogawa H, Okumura K, Okura T, Saito S, Ueno T, et al. SYMPLICITY HTN-Japan: First randomized controlled trial of catheter-based renal denervation in Asian patients. <i>Circ J<\/i> 2015; 79: 1222\u20131229.","DOI":"10.1253\/circj.CJ-15-0150"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. DiBona GF. Nervous kidney: Interaction between renal sympathetic nerves and the renin-angiotensin system in the control of renal function. <i>Hypertension<\/i> 2000; 36: 1083\u20131088.","DOI":"10.1161\/01.HYP.36.6.1083"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Sowers JR, Whaley-Connell A, Epstein M. Narrative review: The emerging clinical implications of the role of aldosterone in the metabolic syndrome and resistant hypertension. <i>Ann Intern Med<\/i> 2009; 150: 776\u2013783.","DOI":"10.7326\/0003-4819-150-11-200906020-00005"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Sutton-Tyrrell K, Newman A, Simonsick EM, Havlik R, Pahor M, Lakatta E, et al. Aortic stiffness is associated with visceral adiposity in older adults enrolled in the study of health, aging, and body composition. <i>Hypertension<\/i> 2001; 38: 429\u2013433.","DOI":"10.1161\/01.HYP.38.3.429"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Tomiyama H, Matsumoto C, Kimura K, Odaira M, Shiina K, Yamashina A. Pathophysiological contribution of vascular function to baroreflex regulation in hypertension. <i>Circ J<\/i> 2014; 78: 1414\u20131419.","DOI":"10.1253\/circj.CJ-14-0064"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Salles GF, Fiszman R, Cardoso CR, Muxfeldt ES. Relation of left ventricular hypertrophy with systemic inflammation and endothelial damage in resistant hypertension. <i>Hypertension<\/i> 2007; 50: 723\u2013728.","DOI":"10.1161\/HYPERTENSIONAHA.107.093120"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Barbaro NR, Fontana V, Modolo R, De Faria AP, Sabbatini AR, Fonseca FH, et al. Increased arterial stiffness in resistant hypertension is associated with inflammatory biomarkers. <i>Blood Press<\/i> 2015; 24: 7\u201313.","DOI":"10.3109\/08037051.2014.940710"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Yamaguchi K, Wakatsuki T, Soeki T, Niki T, Taketani Y, Oeduka H, et al. Effects of telmisartan on inflammatory cytokines and coronary plaque component as assessed on integrated backscatter intravascular ultrasound in hypertensive patients. <i>Circ J<\/i> 2014; 78: 240\u2013247.","DOI":"10.1253\/circj.CJ-13-0741"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. van Bussel BC, Schouten F, Henry RM, Schalkwijk CG, de Boer MR, Ferreira I, et al. Endothelial dysfunction and low-grade inflammation are associated with greater arterial stiffness over a 6-year period. <i>Hypertension<\/i> 2011; 58: 588\u2013595.","DOI":"10.1161\/HYPERTENSIONAHA.111.174557"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Chae CU, Lee RT, Rifai N, Ridker PM. Blood pressure and inflammation in apparently healthy men. <i>Hypertension<\/i> 2001; 38: 399\u2013403.","DOI":"10.1161\/01.HYP.38.3.399"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Dorr O, Liebetrau C, Mollmann H, Gaede L, Troidl C, Rixe J, et al. Soluble fms-like tyrosine kinase-1 and endothelial adhesion molecules (intercellular cell adhesion molecule-1 and vascular cell adhesion molecule-1) as predictive markers for blood pressure reduction after renal sympathetic denervation. <i>Hypertension<\/i> 2014; 63: 984\u2013990.","DOI":"10.1161\/HYPERTENSIONAHA.113.02266"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, et al. 2013 ESH\/ESC guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). <i>Eur Heart J<\/i> 2013; 34: 2159\u20132219.","DOI":"10.1093\/eurheartj\/eht151"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: Results of a survey of echocardiographic measurements. <i>Circulation<\/i> 1978; 58: 1072\u20131083.","DOI":"10.1161\/01.CIR.58.6.1072"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, et al. Expert consensus document on arterial stiffness: Methodological issues and clinical applications. <i>Eur Heart J<\/i> 2006; 27: 2588\u20132605.","DOI":"10.1093\/eurheartj\/ehl254"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Van Bortel LM, Laurent S, Boutouyrie P, Chowienczyk P, Cruickshank JK, De Backer T, et al. Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. <i>J Hypertens<\/i> 2012; 30: 445\u2013448.","DOI":"10.1097\/HJH.0b013e32834fa8b0"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Kirabo A, Fontana V, de Faria AP, Loperena R, Galindo CL, Wu J, et al. DC isoketal-modified proteins activate T cells and promote hypertension. <i>J Clin Invest<\/i> 2014; 124: 4642\u20134656.","DOI":"10.1172\/JCI74084"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. de Faria AP, Fontana V, Modolo R, Barbaro NR, Sabbatini AR, Pansani IF, et al. Plasma 8-isoprostane levels are associated with endothelial dysfunction in resistant hypertension. <i>Clin Chim Acta<\/i> 2014; 433: 179\u2013183.","DOI":"10.1016\/j.cca.2014.03.009"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Savoia C, Schiffrin EL. Inflammation in hypertension. <i>Curr Opin Nephrol Hypertens<\/i> 2006; 15: 152\u2013158.","DOI":"10.1097\/01.mnh.0000203189.57513.76"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Buemi M, Allegra A, Aloisi C, Corica F, Alonci A, Ruello A, et al. Cold pressor test raises serum concentrations of ICAM-1, VCAM-1, and E-selectin in normotensive and hypertensive patients. <i>Hypertension<\/i> 1997; 30: 845\u2013847.","DOI":"10.1161\/01.HYP.30.4.845"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Diep QN, El Mabrouk M, Cohn JS, Endemann D, Amiri F, Virdis A, et al. Structure, endothelial function, cell growth, and inflammation in blood vessels of angiotensin II-infused rats: Role of peroxisome proliferator-activated receptor-gamma. <i>Circulation<\/i> 2002; 105: 2296\u20132302.","DOI":"10.1161\/01.CIR.0000016049.86468.23"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Glowinska B, Urban M, Peczynska J, Florys B. Soluble adhesion molecules (sICAM-1, sVCAM-1) and selectins (sE selectin, sP selectin, sL selectin) levels in children and adolescents with obesity, hypertension, and diabetes. <i>Metabolism<\/i> 2005; 54: 1020\u20131026.","DOI":"10.1016\/j.metabol.2005.03.004"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Nadar SK, Blann AD, Kamath S, Beevers DG, Lip GY. Platelet indexes in relation to target organ damage in high-risk hypertensive patients: A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). <i>J Am Coll Cardiol<\/i> 2004; 44: 415\u2013422.","DOI":"10.1016\/j.jacc.2004.03.067"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Jekell A, Malmqvist K, Wallen NH, Mortsell D, Kahan T. Markers of inflammation, endothelial activation, and arterial stiffness in hypertensive heart disease and the effects of treatment: Results from the SILVHIA study. <i>J Cardiovasc Pharmacol<\/i> 2013; 62: 559\u2013566.","DOI":"10.1097\/FJC.0000000000000017"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Pigott R, Dillon LP, Hemingway IH, Gearing AJ. Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells. <i>Biochem Biophys Res Commun<\/i> 1992; 187: 584\u2013589.","DOI":"10.1016\/0006-291X(92)91234-H"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Gearing AJ, Newman W. Circulating adhesion molecules in disease. <i>Immunol Today<\/i> 1993; 14: 506\u2013512.","DOI":"10.1016\/0167-5699(93)90267-O"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Kakkar AK, Lefer DJ. Leukocyte and endothelial adhesion molecule studies in knockout mice. <i>Curr Opin Pharmacol<\/i> 2004; 4: 154\u2013158.","DOI":"10.1016\/j.coph.2004.01.003"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Moore KJ, Tabas I. Macrophages in the pathogenesis of atherosclerosis. <i>Cell<\/i> 2011; 145: 341\u2013355.","DOI":"10.1016\/j.cell.2011.04.005"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Mochizuki K, Inoue S, Miyauchi R, Misaki Y, Shimada M, Kasezawa N, et al. Plasma sE-selectin level is positively correlated with neutrophil count and diastolic blood pressure in Japanese men. <i>J Nutr Sci Vitaminol (Tokyo)<\/i> 2013; 59: 447\u2013453.","DOI":"10.3177\/jnsv.59.447"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Pierdomenico SD, Lapenna D, Bucci A, Di Tommaso R, Di Mascio R, Manente BM, et al. Cardiovascular outcome in treated hypertensive patients with responder, masked, false resistant, and true resistant hypertension. <i>Am J Hypertens<\/i> 2005; 18: 1422\u20131428.","DOI":"10.1016\/j.amjhyper.2005.05.014"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Spencer CG, Gurney D, Blann AD, Beevers DG, Lip GY; Ascot Steering Committee, Anglo-Scandinavian Cardiac Outcomes Trial. Von Willebrand factor, soluble P-selectin, and target organ damage in hypertension: A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). <i>Hypertension<\/i> 2002; 40: 61\u201366.","DOI":"10.1161\/01.HYP.0000022061.12297.2E"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Ridker PM, Buring JE, Rifai N. Soluble P-selectin and the risk of future cardiovascular events. <i>Circulation<\/i> 2001; 103: 491\u2013495.","DOI":"10.1161\/01.CIR.103.4.491"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Koyama H, Maeno T, Fukumoto S, Shoji T, Yamane T, Yokoyama H, et al. Platelet P-selectin expression is associated with atherosclerotic wall thickness in carotid artery in humans. <i>Circulation<\/i> 2003; 108: 524\u2013529.","DOI":"10.1161\/01.CIR.0000081765.88440.51"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Nurnberger J, Keflioglu-Scheiber A, Opazo Saez AM, Wenzel RR, Philipp T, Schafers RF. Augmentation index is associated with cardiovascular risk. <i>J Hypertens<\/i> 2002; 20: 2407\u20132414.","DOI":"10.1097\/00004872-200212000-00020"},{"key":"37","unstructured":"37. Kahan T. The importance of left ventricular hypertrophy in human hypertension. <i>J Hypertens Suppl<\/i> 1998; 16: S23\u2013S29."},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Smyth SS, Reis ED, Zhang W, Fallon JT, Gordon RE, Coller BS. Beta(3)-integrin-deficient mice but not P-selectin-deficient mice develop intimal hyperplasia after vascular injury: Correlation with leukocyte recruitment to adherent platelets 1 hour after injury. <i>Circulation<\/i> 2001; 103: 2501\u20132507.","DOI":"10.1161\/01.CIR.103.20.2501"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Weller A, Isenmann S, Vestweber D. Cloning of the mouse endothelial selectins: Expression of both E- and P-selectin is inducible by tumor necrosis factor alpha. <i>J Biol Chem<\/i> 1992; 267: 15176\u201315183.","DOI":"10.1016\/S0021-9258(18)42162-X"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Pan J, McEver RP. Regulation of the human P-selectin promoter by Bcl-3 and specific homodimeric members of the NF-kappa B\/Rel family. <i>J Biol Chem<\/i> 1995; 270: 23077\u201323083.","DOI":"10.1074\/jbc.270.39.23077"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Cottone S, Mule G, Nardi E, Lorito MC, Guarneri M, Arsena R, et al. Microalbuminuria and early endothelial activation in essential hypertension. <i>J Hum Hypertens<\/i> 2007; 21: 167\u2013172.","DOI":"10.1038\/sj.jhh.1002109"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. DeSouza CA, Dengel DR, Macko RF, Cox K, Seals DR. Elevated levels of circulating cell adhesion molecules in uncomplicated essential hypertension. <i>Am J Hypertens<\/i> 1997; 10: 1335\u20131341.","DOI":"10.1016\/S0895-7061(97)00268-9"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Marchesi C, Paradis P, Schiffrin EL. Role of the renin-angiotensin system in vascular inflammation. <i>Trends Pharmacol Sci<\/i> 2008; 29: 367\u2013374.","DOI":"10.1016\/j.tips.2008.05.003"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Jilma B, Li-Saw-Hee FL, Wagner OF, Beevers DG, Lip GY. Effects of enalapril and losartan on circulating adhesion molecules and monocyte chemotactic protein-1. <i>Clin Sci (Lond)<\/i> 2002; 103: 131\u2013136.","DOI":"10.1042\/cs1030131"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Rocha R, Rudolph AE, Frierdich GE, Nachowiak DA, Kekec BK, Blomme EA, et al. Aldosterone induces a vascular inflammatory phenotype in the rat heart. <i>Am J Physiol Heart Circ Physiol<\/i> 2002; 283: H1802\u2013H1810.","DOI":"10.1152\/ajpheart.01096.2001"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/80\/5\/80_CJ-16-0058\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T18:19:02Z","timestamp":1655489942000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/80\/5\/80_CJ-16-0058\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-16-0058","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}